ARCHIVED - 8.0 Vaccines


Currently, there are no vaccines approved for use in Canada for the prevention of GAS infections. There are a number of vaccines under development. Recent results of a phase I trial of a multivalent vaccine in the United States have demonstrated significant increases in antibody levels to all six component M antigens used in the vaccine among healthy adult volunteers(77). Results of a phase I trial and preliminary results of a phase II trial for a multivalent vaccine in Canada have also shown high titres of antibodies to 26 targeted serotypes contained in the vaccine among healthy adult volunteers(78,79).There was no evidence of tissue cross-reactive antibodies or vaccine-related serious adverse events among participants for either vaccine.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: